Drug
Diacerein clinical trials
Also written CCP-020, Artrodar and AC-201.
- studies test it
- 37
- open now
- 3
- in phase 3
- 6
- first study started
- 1993
Keep track of what changes. Save the diacerein studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Combined with it in one product
Studies by the year they started
36 studies that test it; most in 2018 (6)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 17
- Phase 3
- 6
- Phase 4
- 9
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
- Gout
- 3
Who runs them
Industry 21 · Other 16
Castle Creek Pharmaceuticals, LLC (7) · TWi Biotechnology, Inc. (6) · Laboratoires NEGMA (3) · TRB Chemedica (2) · University of Campinas, Brazil (2) · Accro Bioscience (Suzhou) Limited (1) · Universitas Sriwijaya (1) · TRB Chemedica International SA (1)
Often tested with
Tested in the same studies.
Eltrombopag (2) · Glucosamine (1) · Chondroitin (1) · Celecoxib (1)
Studies
Open first, then newest update. How each study uses diacerein is read from its arms, and is right about nine times in ten.
Testing it · 37
- Topical Diacerein in Psoriasis VulgarisRecruitingPhase 4Alaa Ashraf Muhammad HelalNCT07352306Written as Diacerein
- Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver DiseaseNot yet recruitingNot applicableHongyan WuNCT07199933Written as Diacerein 50 mg Capsule
- Bioequivalence Study of Diacerein 50 mg Capsule in Healthy Thai VolunteersNot yet recruitingPhase 1International Bio serviceNCT06308068Written as Diacerein 50 mg Capsule
- Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic PatientsActive, not recruitingPhase 3TRB ChemedicaNCT04318041Written as Artrodar
- An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)Active, not recruitingPhase 2/3TWi Biotechnology, Inc.NCT06073132Written as AC-203
- A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque PsoriasisCompletedPhase 2Accro Bioscience (Suzhou) LimitedNCT06972888Written as AC-201
- Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital PalembangCompletedPhase 2/3Universitas SriwijayaNCT06912035Written as Diacerein 50 mg Capsule
- Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee OsteoarthritisCompletedPhase 3TRB Chemedica International SANCT02688400Written as Diacerein
- Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITPCompletedPhase 2Qilu Hospital of Shandong UniversityNCT04917679Written as Eltrombopag plus diacerein
- A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITPCompletedPhase 2Shandong UniversityNCT03754634Written as Eltrombopag and Diacerein
- Study Design of the Diacerein in Patients With Covid-19Status unknownPhase 2University of Campinas, BrazilNCT05226754Written as Diacerein
- A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With GoutCompletedPhase 2TWi Biotechnology, Inc.NCT02287818Written as AC-201
- Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa SimplexCompletedPhase 2Castle Creek Pharmaceuticals, LLCNCT03389308Written as diacerein 1% ointment
- A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy VolunteersCompletedPhase 1Castle Creek Pharmaceuticals, LLCNCT03473184Written as Diacerein 1% ointment
- To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)CompletedPhase 1Castle Creek Pharmaceuticals, LLCNCT03472287Written as Diacerein 1% Ointment
- A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% OintmentCompletedPhase 1Castle Creek Pharmaceuticals, LLCNCT03472534Written as diacerein 1% ointment
- A 6-Week Study to Evaluate the Photoallergic Potential of Diacerein 1% Ointment in Healthy VolunteersCompletedPhase 1Castle Creek Pharmaceuticals, LLCNCT03473197Written as Diacerein 1% ointment
- Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)TerminatedPhase 2Castle Creek Pharmaceuticals, LLCNCT03154333Written as diacerein 1% ointment
- A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy SubjectsCompletedPhase 1Castle Creek Pharmaceuticals, LLCNCT03472547Written as diacerein 1% ointment
- A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous PemphigoidTerminatedPhase 2TWi Biotechnology, Inc.NCT03286582Written as AC-203 1% Topical Ointment
Codes
What other systems call diacerein · ClinicalTrials.gg INT002809
- MeSH (NLM) C025292diacereinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4HU6J11EL5DIACEREINConfirmed FDA, NLM, Wikidata
- RxNorm 22759Confirmed FDA, Wikidata
- Wikidata Q413178diacereinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166759DiacereinOne source FDA
- DrugBank DB11994One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C025292 | diacerein | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4HU6J11EL5 | DIACEREIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 22759 | — | Confirmed FDA, Wikidata |
| Wikidata | Q413178 | diacerein | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166759 | Diacerein | One source FDA |
| DrugBank | DB11994 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.